China’s 2009 Regulatory Changes Will Affect Makers of Drugs, APIs and Devices
• By PharmAsia News
BEIJING - An array of regulatory and legal changes covering pharmaceuticals and medical devices in China is likely to be launched or broadened this year, including new GMP guidelines, as the country aims to upgrade supervision of the entire health care sector, according to a leading Chinese lawyer in the area of life sciences-related issues and legislation
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
